Live Markets
Saturday, September 12, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Daxor Corporation (DXR)

NCM · Medical Instruments & Supplies

$11.47+0.63 (+5.81%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$67.0M
P/E (TTM)
6.41
EPS
$1.79
Div Yield
52W Range
$8.56–$14.76
Beta
0.26

Company overview

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Peers in Medical Instruments & Supplies

All in industry →

Recent press releases

Daxor Corporation has not issued a press release in this window.

SEC filings

All filings →

Daxor Corporation has not filed an SEC document in this window.

Daxor Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
49,028 sh0.0%
28,221 sh-2.4%
500 sh● NEW
3,128 sh0.0%
90 sh● NEW
3,237 sh-8.5%
5 sh+25.0%

People at Daxor Corporation

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Daxor Corporation.